BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 11517152)

  • 1. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
    Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
    Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse.
    Moore JP; Morrison DG; Hyde JF
    Endocrinology; 1994 May; 134(5):2005-10. PubMed ID: 7512494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin within the normal and hyperplastic anterior pituitary gland: localization, secretion, and functional analysis in normal and human growth hormone-releasing hormone transgenic mice.
    Moore JP; Cai A; Maley BE; Jennes L; Hyde JF
    Endocrinology; 1999 Apr; 140(4):1789-99. PubMed ID: 10098517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
    Luque RM; Soares BS; Peng XD; Krishnan S; Cordoba-Chacon J; Frohman LA; Kineman RD
    Endocrinology; 2009 Jul; 150(7):3177-85. PubMed ID: 19342460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine hydroxylase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function.
    Kineman RD; Aleppo G; Frohman LA
    Endocrinology; 1996 Nov; 137(11):4630-6. PubMed ID: 8895326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretagogues and the somatotrope: signaling and proliferation.
    Frohman LA; Kineman RD; Kamegai J; Park S; Teixeira LT; Coschigano KT; Kopchic JJ
    Recent Prog Horm Res; 2000; 55():269-90; discussion 290-1. PubMed ID: 11036941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and localization of an immunoreactive growth hormone-releasing hormone precursor form in normal and tumoral human anterior pituitaries.
    Rauch C; Li JY; Croissandeau G; Berthet M; Peillon F; Pagesy P
    Endocrinology; 1995 Jun; 136(6):2594-601. PubMed ID: 7750482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
    Kovacs M; Schally AV; Lee EJ; Busto R; Armatis P; Groot K; Varga JL
    J Endocrinol; 2002 Nov; 175(2):425-34. PubMed ID: 12429040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis.
    Lloyd RV; Jin L; Chang A; Kulig E; Camper SA; Ross BD; Downs TR; Frohman LA
    Am J Pathol; 1992 Oct; 141(4):895-906. PubMed ID: 1415483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH.
    Kineman RD; Luque RM
    Endocrinology; 2007 Sep; 148(9):4440-9. PubMed ID: 17540720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary hormone gene expression and secretion in human growth hormone-releasing hormone transgenic mice: focus on lactotroph function.
    Moore JP; Cai A; Hostettler ME; Arbogast LA; Voogt JL; Hyde JF
    Endocrinology; 2000 Jan; 141(1):81-90. PubMed ID: 10614626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
    Xu X; Bennett SA; Ingram RL; Sonntag WE
    Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
    Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.